Acorda Therapeutics Inc (NASDAQ:ACOR)

34.49
Delayed Data
As of Apr 17
 -0.19 / -0.55%
Today’s Change
28.26
Today|||52-Week Range
45.45
-15.61%
Year-to-Date

Today’s Trading

Previous close34.68
Today’s open34.50
Day’s range33.71 - 34.88
Volume623,511
Average volume (3 months)739,286
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-147.31%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio83.0
Price/Sales4.19
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.16+0.50%
MACKMerrimack Pharmaceut...-0.20-1.54%
USNAUSANA Health Science...-2.72-2.25%
ZIOPZIOPHARM Oncology In...-0.04-0.29%
Data as of 4:02pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers